Onychomycosis Associated with Superficial Skin Infection Due to Aspergillus sydowii in an Immunocompromised Patient

  • Parismita Borgohain
  • Purnima BaruaEmail author
  • Pranjal Jyoti Dutta
  • Dipika Shaw
  • Shivaprakash M. Rudramurthy
Case Report


Opportunistic fungal infections of the skin and nail are frequently encountered in human. Recent years have shown increased incidence of fungal infections especially in immunocompromised patients. Onychomycosis in HIV-infected patients is reported to occur in 15–40%, four times more than in the general population. Here, we report a case of fingernail proximal subungual onychomycosis with associated skin infection caused by an opportunistic mold, Aspergillus sydowii, in a HIV positive individual. Isolation of A. sydowii from nail and skin of an immunocompromised person needs accurate identification for successful treatment.


Onychomycosis Proximal subungual onychomycosis Aspergillus spp. Immunocompromised patient 


Authors Contribution

We declare that this work was done by the authors named in this case report with equal contributions.

Compliance with Ethical Standards

Conflict of interest

None of the authors have any conflict of interest to declare.

Ethical Approval

Obtained (Reference No. SMEJ/JMCH/MEU/841/Pt-1/2011/3050).

Informed Consent

Both verbal and written consents were obtained from the patient.


  1. 1.
    Ahmadi B, Hashemi SJ, Zaini F, Shidfar MR, Moazeni M, Mousavi B, Noorbakhsh F, Gheramishoar M, Rezaie S. A case of onychomycosis caused by Aspergillus candidus. Med Mycol Case Rep. 2012;3:45–8. Scholar
  2. 2.
    Al-Hatmi AM, Castro MA, De Hoog GS, Badali H, Alvarado VF, Verweij PE, Meis JF, Zago VV. Epidemiology of Aspergillus species causing keratitis in Mexico. Mycoses. 2019;62:144–51. Scholar
  3. 3.
    Banu A, Anand M, Eswari L. A rare case of onychomycosis in all 10 fingers of an immunocompetent patient. Indian Dermatol Online J. 2013;4:302–4. Scholar
  4. 4.
    Barua P, Mahanta J, Barua N. Onychomycosis in green tea leaf pluckers: a clinicomycological study. Int J Infect Dis. 2012;2012(16):319. Scholar
  5. 5.
    Bongomin F, Batac CR, Richardson MD, Denning DW. A review of onychomycosis due to Aspergillus species. Mycopathologia. 2018;183:485–93. Scholar
  6. 6.
    Bonnal C, Leleu C, Brugiere O, Chochillon C, Porcher R, Boelle PY, Menotti J, Houze S, Lucet JC, Derouin F. Relationship between fungal colonisation of the respiratory tract in lung transplant recipients and fungal contamination of the hospital environment. PLoS ONE. 2015;10:e0144044. Scholar
  7. 7.
    Bouchara JP, Chaturvedi V. The curious case of “Case Report” of infections caused by human and animal fungal pathogens: an educational tool, an online archive, or a format in need of retooling. Mycopathologia. 2018;183:879–91. Scholar
  8. 8.
    Brasch J, Varga J, Jensen JM, Egberts F, Tintelnot K. Nail infection by Aspergillus ochraceopetaliformis. Med Mycol. 2009;47:658–62.CrossRefGoogle Scholar
  9. 9.
    Castro C, Galan-Sanchez F, Linares MJ, Tejero R, Ruiz M, Serrano ML, Rodriguez-Iglesias M, Martin-Mazuelos E. FUNGAE-IFI Study Group. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns. Med mycol. 2018;57:412–20. Scholar
  10. 10.
    Choudhary VS, Koley S, Mallick S, Bose S, Basak S. Proximal subungual proximal subungual onychomycosis caused by onychomycosis caused by Aspergillus flavus in a in a HIV-positive patient. Indian J Dermatol Venereol Leprol. 2009;75:410–2. Scholar
  11. 11.
    Conant MA. The AIDS epidemic. J Am Acad Dermatol. 1994;31:47–50.CrossRefGoogle Scholar
  12. 12.
    Cribier B, Mena ML, Rey D, Partisani M, Fabien V, Lang JM, Grosshans E. Nail changes in patients infected with human immunodeficiency virus: a prospective controlled study. Arch Dermatol. 1998;134:1216–20.Google Scholar
  13. 13.
    Ein-Gil N, Ilan M, Carmeli S, et al. Presence of Aspergillus sydowii, a pathogen of gorgonian sea fans in the marine sponge Spongia obscura. ISME J. 2009;3:752–5.CrossRefGoogle Scholar
  14. 14.
    Elewski BE, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol. 1997;133:1172–3.CrossRefGoogle Scholar
  15. 15.
    Elewski BE, Hay RJ. Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy. Clin Infect Dis. 1996;23:305–13.CrossRefGoogle Scholar
  16. 16.
    English MP. Nails and fungi. Br J Dermatol. 1976;94:697–701.CrossRefGoogle Scholar
  17. 17.
    Fernandez M, Cattana M, Rojas F, Sosa LM, Aguirre C, Vergara M, Giusiano G. Aspergillus species in hospital environments with pediatric patients in critical condition. Rev Iberoam Micol. 2014;31:176–81. Scholar
  18. 18.
    Ganju SA, Bhagra S, Kanga AK. Onychomycosis due to Aspergillus niger with concomitant multiple fungal infections in a human immunodeficiency virus infected person. CHRISMED J Health Res. 2015;2:257–61. Scholar
  19. 19.
    Ghannoum M, Isham N. Fungal nail infections (onychomycosis): a never-ending story? PLoS Pathog. 2014;10:1–5. Scholar
  20. 20.
    Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641–8.CrossRefGoogle Scholar
  21. 21.
    Gianni C, Romano C. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine. Dermatology. 2004;209:104–10. Scholar
  22. 22.
    Goodman DS, Teplitz ED, Wishner A, Klein RS, Burk PG, Hershenbaum E. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol. 1987;17:210–20.CrossRefGoogle Scholar
  23. 23.
    Gupta AK, Taborda P, Taborda V, Gilmour J, Rachlis A, Salit I, Gupta MA, MacDonald P, Cooper EA, Summerbell RC. Epidemiology and prevalence of onychomycosis in HIV positive individuals. Int J Dermatol. 2000;39:746–53.CrossRefGoogle Scholar
  24. 24.
    Gupta M, Sharma NL, Kanga AK, Mahajan VK, Tegta GR. Onychomycosis: clinico-mycologic study of 130 patients from Himachal Pradesh, India. Indian J Dermatol Venereol Leprol. 2007;73:389–92. Scholar
  25. 25.
    Haneke E, Roseeuw D. The scope of onychomycosis: epidemiology and clinical features. Int J Dermatol. 1999;38(Suppl 2):7–12.CrossRefGoogle Scholar
  26. 26.
    Harika DR, Usharani A. A study of Onychomycosis in Krishna district of Andhra Pradesh, India. Our Dermatol Online. 2015;6:384–91. Scholar
  27. 27.
    Herman LG. Aspergillus in patient care areas. Ann N Y Acad Sci. 1980;353:140–6.CrossRefGoogle Scholar
  28. 28.
    Hwang SM, Suh MK, Ha GY. Onychomycosis due to nondermatophytic molds. Ann Dermatol. 2012;24:175–80. Scholar
  29. 29.
    Kaplan MH, Sadick N, McNutt NS, Meltzer M, Sarngadharan MG, Pahwa S. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). JAAD. 1987;16:485–506.CrossRefGoogle Scholar
  30. 30.
    Kara AY, Erdogan GF, Cologlu D. A case of onychomycosis due to Aspergillus flavus in all fingernails and toenails of an immunocompromised patient. J Clin Exp Dermatol Res. 2018;9:1–3.Google Scholar
  31. 31.
    Karmakar S, Kalla G, Joshi KR, Karmakar S. Dermatophytosis in a desert district of western Rajasthan. Indian J Dermatol Venereal Leprol. 1995;61:280–3.Google Scholar
  32. 32.
    Kaur R, Kashyap B, Bhalla P. Onychomycosis-epidemiology, diagnosis and management. Indian J Med Microbiol. 2008;26:108–16. Scholar
  33. 33.
    Kim DM, Suh MK, Ha GY, Sohng SH. Fingernail onychomycosis due to Aspergillus niger. Ann Dermatol. 2012;24:459–63. Scholar
  34. 34.
    Kim K, Harvell CD. The rise and fall of a six-year coral-fungal epizootic. Am Nat. 2004;164(Suppl 5):S52–63.CrossRefGoogle Scholar
  35. 35.
    McCarthy JD. Origins of onychomycosis. Clin Podiatr Med Surg. 1995;12:221–48.Google Scholar
  36. 36.
    Nagarajan C, Thayanidhi P, Kindo AJ, Ramaraj V, Mohanty S, Arunachalam R. Fungal Rhinosinusitis: report of uncommon Aspergillus species as etiological agents. Int J Case Rep Images. 2014;5:13–7.CrossRefGoogle Scholar
  37. 37.
    Nouripour-Sisakht S, Mirhendi H, Shidfar MR, Ahmadi B, Rezaei-Matehkolaei A, Geramishoar M, Zarei F, Jalalizand N. Aspergillus species as emerging causative agents of onychomycosis. J Mycol Med. 2015;25:101–7. Scholar
  38. 38.
    Ogasawara Y. Prevalence and patient’s consciousness of tinea pedis and onychomycosis. Nihon Ishinkin Gakkai Zasshi. 2003;44:253–60.CrossRefGoogle Scholar
  39. 39.
    Phillips P. New drugs for the nail fungus prevalent in elderly. JAMA. 1996;276:12–3.CrossRefGoogle Scholar
  40. 40.
    Piraccini MB, Alessandrini A. Onychomycosis: a review. J Fungi. 2015;1:30–43. Scholar
  41. 41.
    Pitt JI, Hocking AD. Aspergillus flavus link. Fungi and food spoilage. 3rd ed. New York: Springer; 2009. p. 305–11.CrossRefGoogle Scholar
  42. 42.
    Ravnborg L, Baastrup N, Svejgaard E. Onychomycosis in HIV-infected patients. Acta Derm Venereol. 1998;78:151–2.CrossRefGoogle Scholar
  43. 43.
    Schmidt BM, Holmes C. Proximal white onychomycosis in an immunocompetent patient: a case report. CRCM. 2015;4:41–4. Scholar
  44. 44.
    Seyedmousavi S, Guillot J, Arné P, De Hoog GS, Mouton JW, Melchers WJ, Verweij PE. Aspergillus and aspergilloses in wild and domestic animals: a global health concern with parallels to human disease. Med Mycol. 2015;53:765–97. Scholar
  45. 45.
    Shivaprakash MR, Singh G, Gupta P, Dhaliwal M, Kanwar AJ, Chakrabarti A. Extensive white piedra of the scalp caused by Trichosporon inkin: a case report and review of literature. Mycopathologia. 2011;172:481–6. Scholar
  46. 46.
    Sobhanadri C, Rao DT, Babu KS. Clinical and mycological study of superficial fungal infections at Government General Hospital: Guntur and their response to treatment with Hamycin, Dermostatin and Dermamycin. Indian J Dermatol Venereol. 1970;36:209–14.Google Scholar
  47. 47.
    Suh JC, Yeum JS, Na GY, Seo SK, Suh MK. A simple detection method of the resistance to the treatment of onychomycosis: a case report of Aspergillus sydowii onychomycosis. Ann Dermatol. 2001;13:62–5.CrossRefGoogle Scholar
  48. 48.
    Summerbell R, Howard DH. Pathogenic fungi in humans and animals. Ascomycetes: Aspergillus, Fusarium, Sporothrix, Piedraia and their relatives. 2nd ed. New York: Marcell Decker; 2003.Google Scholar
  49. 49.
    Takahata Y, Hiruma M, Sugita T, Muto M. A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis. Mycoses. 2008;51:170–3.CrossRefGoogle Scholar
  50. 50.
    Tsang CC, Hui TW, Lee KC, Chen JH, Ngan AH, Tam EW, Chan JF, Wu AL, Cheung M, Brian PH, Wu AK. Genetic diversity of Aspergillus species isolated from onychomycosis and Aspergillus hongkongensis sp. nov., with implications to antifungal susceptibility testing. Diagn Microbiol Infect Dis. 2016;8:125–34. Scholar
  51. 51.
    Walshe MM, English MP. Fungi in nails. Br J Dermatol. 1966;78:198–207.CrossRefGoogle Scholar
  52. 52.
    Ward J (2018) Aspergillus sydowii. Published 12 Sept 2018
  53. 53.
    Wayne PA (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. CLSI document M38-A2Google Scholar
  54. 54.
    Yamada A, Noguch H, Sakae H, Sugita T, Hiruma M, Hiruma M. A case of onychomycosis caused by Aspergillus sydowii. Med Mycol J. 2012;53:205–9. Scholar
  55. 55.
    Zaias N, Glick B, Rebell G. Diagnosing and treating onychomycosis. J Fam Pract. 1996;42:513–9.Google Scholar
  56. 56.
    Zaias N, Oertel IN, Elliott DF. Fungi in toe nails. J Invest Dermatol. 1969;53:140–2.CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of MicrobiologyJorhat Medical CollegeJorhatIndia
  2. 2.Department of DermatologyJorhat Medical CollegeJorhatIndia
  3. 3.Department of Medical MicrobiologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations